Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia (Borden-001)

This study has been completed.
The Leukemia and Lymphoma Society
Information provided by:
Jewish General Hospital Identifier:
First received: November 15, 2007
Last updated: May 6, 2011
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)